12/21
Headlines

Mark DeFrance

Mark DeFrance is a senior research analyst at Tech Insider, focusing on the enterprise software sector. Prior to joining TI, Mark covered enterprise software for First Albany, and prior to that he worked in equity research at B.T. Alex Brown and Bankers Trust. Mark has written software applications in various programming languages including BASIC, Pascal, and COBOL. He has also been recognized in The Wall Street Journal's "Best on the Street" survey and was recognized by Forbes Magazine as the No. 1 sell-side stock picker in the software industry for a five-year period, with returns of 115% versus 26% for the software industry.

Social Stocks In News: Facebook Inc (NASDAQ:FB), Twitter Inc (NYSE:TWTR), Yelp Inc (NYSE:YELP), Zynga Inc (NASDAQ:ZNGA)

Mark DeFrance02 mins

Facebook Inc (NASDAQ:FB) Chief Executive Mark Zuckerberg blasted the U.S. government’s electronic surveillance practices on Thursday, saying he’d personally called President Barack Obama to voice his displeasure. Facebook Inc (NASDAQ:FB) stock performance was -2.89% in last session and finished the day at $68.83. Traded volume was 56,886,692 million shares in the last session and the…

Read More

Biotech Gainers: Geron Corporation (NASDAQ:GERN), Chelsea Therapeutics International (NASDAQ:CHTP), TESARO Inc (NASDAQ:TSRO), Vanda Pharmaceuticals (NASDAQ:VNDA)

Mark DeFrance02 mins

Geron Corp. (NASDAQ:GERN)‘s stock had its “positive” rating reaffirmed by equities researchers at Wells Fargo & Co. in a research report issued on Thursday, AnalystRatings.NETreports. Geron Corporation (NASDAQ:GERN) stock performance was 5.62% in last session and finished the day at $1.78. Traded volume was 16,397,352 million shares in the last session and the average volume…

Read More

Services Sector Unusual Volume: Krispy Kreme (NYSE:KKD), Scientific Games (NASDAQ:SGMS), CTC Media (NASDAQ:CTCM), Home Inns & Hotels (NASDAQ:HMIN)

Mark DeFrance02 mins

Fourth-quarter profits for Krispy Kreme (NYSE:KKD) more than tripled year over year, with the company now having approximately 800 locations worldwide. Krispy Kreme Doughnuts (NYSE:KKD) stock performance was 1.16% in last session and finished the day at $20.11. Traded volume was 5,517,121million shares in the last session and the average volume of the stock remained…

Read More

Biotech Unusual Volume Stocks: Arca Biopharma (NASDAQ:ABIO), Biota Pharmaceuticals (NASDAQ:BOTA), Lpath (NASDAQ:LPTN), La Jolla Pharmaceutical (NASDAQ:LJPC)

Mark DeFrance02 mins

Arca Biopharma Inc (NASDAQ:ABIO) focuses on developing genetically targeted therapies for cardiovascular disease. Its lead product candidate, Gencaro, is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for the prevention of atrial fibrillation in patients with heart failure and reduced left ventricular ejection fraction. Arca Biopharma Inc (NASDAQ:ABIO) stock performance was 11.34% in…

Read More

Services Sector Most Active Stocks: Sirius XM Holdings (NASDAQ:SIRI), Rite Aid (NYSE:RAD), American Eagle Outfitters (NYSE:AEO), Hertz Global (NYSE:HTZ)

Mark DeFrance02 mins

Sirius XM Holdings Inc. (NASDAQ:SIRI) announced it will air The Affordable Care Act: An Urban View Roundtable, an in-depth discussion moderated by Sirius XM host Joe Madison featuring a panel with Kathleen Sebelius, Secretary of Health and Human Services, discussing the history, benefits, and practical applications of the Affordable Care Act. Sirius XM Holdings Inc….

Read More

Biotech Unusual Volume: Northwest Biotherapeutics (NASDAQ:NWBO), La Jolla Pharmaceutical Company (NASDAQ:LJPC), OXiGENE (NASDAQ:OXGN), Tengion (OTCMKTS:TNGN)

Mark DeFrance02 mins

Northwest Biotherapeutics Inc (NASDAQ:NWBO) a biotechnology company developing DCVax personalized immune therapies for solid tumour cancers, has received approval from the Paul Ehrlich Institute (PEI- the FDA of Germany) of a “Hospital Exemption” early access programme under Section 4b of the German Drug Law. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 16.93% in last session…

Read More